Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients - The SAUNA Trial

NCT05701241 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT05701241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05701241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients - The SAUNA Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 4
Overall status
Recruiting
Start date
June 28, 2023
Completion date
April 30, 2034
Enrollment
270 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteropancreatic neuroendocrine tumor